414 related articles for article (PubMed ID: 31645275)
1. Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies.
Mazepa MA; Park YA; Raval JS
Transfus Med Rev; 2019 Oct; 33(4):248-255. PubMed ID: 31645275
[TBL] [Abstract][Full Text] [Related]
2. When targeted therapies alleviate the burden of TPE: The example of immune-mediated TTP.
Picod A; Coppo P
Transfus Apher Sci; 2019 Jun; 58(3):273-277. PubMed ID: 31018909
[TBL] [Abstract][Full Text] [Related]
3. A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.
Coppo P; Bubenheim M; Azoulay E; Galicier L; Malot S; Bigé N; Poullin P; Provôt F; Martis N; Presne C; Moranne O; Benainous R; Dossier A; Seguin A; Hié M; Wynckel A; Delmas Y; Augusto JF; Perez P; Rieu V; Barbet C; Lhote F; Ulrich M; Rumpler AC; de Witte S; Krummel T; Veyradier A; Benhamou Y
Blood; 2021 Feb; 137(6):733-742. PubMed ID: 33150928
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic Thrombocytopenic Purpura: Beyond Empiricism and Plasma Exchange.
Tsai HM
Am J Med; 2019 Sep; 132(9):1032-1037. PubMed ID: 30928346
[TBL] [Abstract][Full Text] [Related]
5. Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP).
Chen M; Shortt J
Transfus Med Rev; 2022 Oct; 36(4):204-214. PubMed ID: 36396570
[TBL] [Abstract][Full Text] [Related]
6. Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura.
Poullin P; Bornet C; Veyradier A; Coppo P
Drugs Today (Barc); 2019 Jun; 55(6):367-376. PubMed ID: 31250841
[TBL] [Abstract][Full Text] [Related]
7. Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
Kubo M; Matsumoto M
Int J Hematol; 2023 Mar; 117(3):331-340. PubMed ID: 36757521
[TBL] [Abstract][Full Text] [Related]
8. Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura.
Picod A; Coppo P
Expert Rev Hematol; 2019 Jun; 12(6):461-471. PubMed ID: 31092093
[No Abstract] [Full Text] [Related]
9. Therapeutic plasma exchange in thrombotic thrombocytopenic purpura.
Picod A; Provôt F; Coppo P
Presse Med; 2019 Nov; 48(11 Pt 2):319-327. PubMed ID: 31759790
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of immune-mediated thrombotic thrombocytopenic purpura: A decisive turning point].
Poullin P
Transfus Clin Biol; 2021 Nov; 28(4):380-385. PubMed ID: 34464709
[TBL] [Abstract][Full Text] [Related]
11. Caplacizumab: a change in the paradigm of thrombotic thrombocytopenic purpura treatment.
le Besnerais M; Veyradier A; Benhamou Y; Coppo P
Expert Opin Biol Ther; 2019 Nov; 19(11):1127-1134. PubMed ID: 31359806
[No Abstract] [Full Text] [Related]
12. COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report.
Schwaegermann MK; Hobohm L; Rausch J; Reuter M; Griemert TF; Sivanathan V; Falter T; Sprinzl MF; Lackner KJ; Galle PR; Konstantinides S; Theobald M; von Auer C
Hamostaseologie; 2023 Jun; 43(3):215-218. PubMed ID: 34327693
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of adjunct therapies in acquired thrombotic thrombocytopenia purpura.
Racine-Brzostek SE; Shi PA
Transfusion; 2019 Aug; 59(8):2496-2498. PubMed ID: 31283011
[TBL] [Abstract][Full Text] [Related]
14. Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura.
Dane K; Chaturvedi S
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):539-547. PubMed ID: 30504355
[TBL] [Abstract][Full Text] [Related]
15. Caplacizumab for relapsing thrombotic thrombocytopenic purpura.
Kaczmarek V; Holle J; Astudillo R; Kempf C; Bufler P; Müller D
Pediatr Nephrol; 2019 Sep; 34(9):1625-1628. PubMed ID: 31177334
[TBL] [Abstract][Full Text] [Related]
16. Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes.
Kucukyurt S; Eskazan AE
J Blood Med; 2020; 11():319-326. PubMed ID: 33061729
[TBL] [Abstract][Full Text] [Related]
17. Caplacizumab: A game changer also in pregnancy-associated immune-mediated thrombotic thrombocytopenic purpura?
Coppo P; Joly BS;
Br J Haematol; 2023 Aug; 202(4):725-727. PubMed ID: 37291806
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.
Matsumoto M; Miyakawa Y; Kokame K; Ueda Y; Wada H; Higasa S; Yagi H; Ogawa Y; Sakai K; Miyata T; Morishita E; Fujimura Y;
Int J Hematol; 2023 Nov; 118(5):529-546. PubMed ID: 37689812
[TBL] [Abstract][Full Text] [Related]
19. Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura.
Zheng XL; Vesely SK; Cataland SR; Coppo P; Geldziler B; Iorio A; Matsumoto M; Mustafa RA; Pai M; Rock G; Russell L; Tarawneh R; Valdes J; Peyvandi F
J Thromb Haemost; 2020 Oct; 18(10):2503-2512. PubMed ID: 32914535
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management.
Sukumar S; Lämmle B; Cataland SR
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
